![](/img/cover-not-exists.png)
A07Crizotinib in ROS1 rearranged or MET deregulated Non-Small-Cell Lung Cancer (NSCLC): Preliminary results of the METROS trial
Landi, L., Chiari, R., Delmonte, A., Morabito, A., Tamberi, S., Barbieri, F., Buosi, R., Gridelli, C., Tiseo, M., Gebbia, V., Fontanini, G., Crinò, L., Cappuzzo, F.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw332.07
Date:
September, 2016
File:
PDF, 65 KB
english, 2016